Some children may exhibit recurrent episodes of otitis media and/or -otitis media with effusion. Treatment of severe cases may involve the placement of a pressure equalization tube or tympanostomy tube through the tympanic membrane to provide adequate drainage of the middle ear by providing fluid communication between the middle and outer ear. In particular, such a tube may provide a vent path that promotes drainage of fluid from the middle ear via the Eustachian tube and may thus reduce stress imposed on the tympanic membrane from pressure within the middle ear. This may further reduce the likelihood of future infections and pressure induced ruptures of the tympanic membrane. Pressure equalization tubes may fall out spontaneously within about a year of placement. Exemplary pressure equalization tube delivery systems are disclosed in U.S. Pat. No. 8,052,693, entitled “System and Method for the Simultaneous Automated Bilateral Delivery of Pressure Equalization Tubes,” issued Nov. 8, 2011, the disclosure of which is incorporated by reference herein. Additional exemplary pressure equalization tube delivery systems are disclosed in U.S. Pat. No. 8,249,700, entitled “System and Method for the Simultaneous Bilateral Integrated Tympanic Drug Delivery and Guided Treatment of Target Tissues within the Ears,” issued Aug. 21, 2012, the disclosure of which is incorporated by reference herein. Still additional exemplary pressure equalization tube delivery systems are disclosed in U.S. Pub. No. 2011/0015645, entitled “Tympanic Membrane Pressure Equalization Tube Delivery System,” published Jan. 20, 2011, the disclosure of which is incorporated by reference herein.
Insertion of a pressure equalization tube may be performed using general anesthesia in some cases, which may require additional resources such as an operating room, the presence of an anesthesiologist, and time in a recovery room. Furthermore, the use of general anesthesia may include certain risks that a patient may or may not be comfortable with undertaking. Some pressure equalization tube delivery systems and methods provide a local anesthetic through iontophoresis. Examples of such systems and methods are disclosed in U.S. Pub. No. 2010/0198135, entitled “Systems and Methods for Anesthetizing Ear Tissue,” published Aug. 5, 2010, the disclosure of which is incorporated by reference herein. Additional examples of such systems and methods are disclosed in U.S. Pat. No. 8,192,420, entitled “Iontophoresis Methods,” issued Jun. 5, 2012, the disclosure of which is incorporated by reference herein.
While a variety of pressure equalization tube delivery systems and methods have been made and used, it is believed that no one prior to the inventor(s) has made or used an invention as described herein.
It is believed the present invention will be better understood from the following description of certain examples taken in conjunction with the accompanying drawings, in which like reference numerals identify the same elements and in which:
The drawings are not intended to be limiting in any way, and it is contemplated that various embodiments of the invention may be carried out in a variety of other ways, including those not necessarily depicted in the drawings. The accompanying drawings incorporated in and forming a part of the specification illustrate several aspects of the present invention, and together with the description serve to explain the principles of the invention; it being understood, however, that this invention is not limited to the precise arrangements shown.
The following description of certain examples of the technology should not be used to limit its scope. Other examples, features, aspects, embodiments, and advantages of the technology will become apparent to those skilled in the art from the following description, which is by way of illustration, one of the best modes contemplated for carrying out the technology. As will be realized, the technology described herein is capable of other different and obvious aspects, all without departing from the technology. Accordingly, the drawings and descriptions should be regarded as illustrative in nature and not restrictive.
It is further understood that any one or more of the teachings, expressions, embodiments, examples, etc. described herein may be combined with any one or more of the other teachings, expressions, embodiments, examples, etc. that are described herein. The following-described teachings, expressions, embodiments, examples, etc. should therefore not be viewed in isolation relative to each other. Various suitable ways in which the teachings herein may be combined will be readily apparent to those of ordinary skill in the art in view of the teachings herein. Such modifications and variations are intended to be included within the scope of the claims.
As noted above, a pressure equalization (PE) tube may be delivered to the tympanic membrane (TM) of a patient as a way of treating, for example, otitis media. In some instances, a delivery instrument may be used to insert PE tubes in the tympanic membrane (TM) without the use of general anesthesia.
As shown in
By way of example only, PETDD (10) may be constructed and operable in accordance with at least some of the teachings of U.S. Pat. No. 8,052,693, the disclosure of which is incorporated by reference herein; U.S. Pat. No. 8,249,700, the disclosure of which is incorporated by reference herein; U.S. Pub. No. 2011/0015645, the disclosure of which is incorporated by reference herein; and/or U.S. Pub. No. 2014/0276906, entitled “Features to Improve and Sense Tympanic Membrane Apposition by Tympanostomy Tube Delivery Instrument,” filed on even date herewith, the disclosure of which is incorporated by reference herein. Other suitable forms that PETDD (10) may take will be apparent to those of ordinary skill in the art in view of the teachings herein. It should also be understood that a PE tube may be inserted in a tympanic membrane (TM) manually, such as by creating the myringotomy incision with a knife and inserting the PE tube using forceps, etc.
By way of example only, PE tube (20) may also be configured in accordance with at least some of the teachings of U.S. Pat. No. 9,011,363, entitled “Tympanic Membrane Pressure Equalization Tube,” issued Apr. 21, 2015, the disclosure of which is incorporated by reference herein; and/or at least some of the teachings U.S. Pub. No. 2014/0276906, the disclosure of which is incorporated by reference herein. Other suitable forms that PE tube (20) may take will be apparent to those of ordinary skill in the art in view of the teachings herein.
As noted above, PETDD (10) may be used in conjunction with an iontophoresis system, which may be used to anesthetize the patient's ear before PETDD (10) is inserted into the patient's ear canal to deliver PE tube (20) in the tympanic membrane (TM). By way of example only, iontophoresis may be provided in accordance with at least some of the teachings of U.S. Pub. No. 2010/0198135, the disclosure of which is incorporated by reference herein; and/or in accordance with at least some of the teachings of U.S. Pat. No. 8,192,420, the disclosure of which is incorporated by reference herein. In addition or in the alternative, iontophoresis may be provided in accordance with any of the various teachings below. It should be understood that any of the below teachings may be readily combined with at least some of the teachings of U.S. Pub. No. 2010/0198135, the disclosure of which is incorporated by reference herein; and/or at least some of the teachings of U.S. Pat. No. 8,192,420, the disclosure of which is incorporated by reference herein.
In some versions, earplug (220) is configured and operable in accordance with at least some of the teachings of U.S. Pub. No. 2014/0102461, entitled “Adhesive Earplugs Useful for Sealing the Ear Canal,” published Apr. 17, 2014, the disclosure of which is incorporated by reference herein. As best seen in
Sealing element (224) is secured to a rigid frame (223), which defines gripping features (222). Sealing element (224) and frame (223) also together define a working channel (221). Frame (223) defines a plurality of vent paths (229) in fluid communication with working channel (221). Vent paths (229) are configured to allow air to escape working channel (221) while working channel (221) fills with iontophoresis solution; yet are further configured prevent iontophoresis solution from escaping working channel (221) via vent paths (229) once working channel (221) is filled with iontophoresis solution. An iontophoresis electrode (252) in the form of a coil extends along at least part of the length of working channel (221). It should be understood that iontophoresis electrode (252) may have any other suitable configuration. Iontophoresis electrode (252) is coupled with control unit (170) via a cable (250) and is thereby operable to be activated with a positive voltage as described above. Thus, control unit (170) may activate iontophoresis electrode (252) to provide an electrorepulsive force to the iontophoresis solution ions delivered through apertures (227), to drive the anesthetic of the iontophoresis solution ions into the tympanic membrane (TM) for anesthetization of the tympanic membrane (TM) as described above.
It should be understood that the above described iontophoresis system (200) may be varied in numerous ways. Several examples of how iontophoresis system (200) may be varied will be described in greater detail below, while still other examples will be apparent to those of ordinary skill in the art in view of the teachings herein. While the various iontophoresis systems described herein have been mentioned in relation to PETDD (10) and PE tube (20) delivery, it should be understood that any of the iontophoresis systems described herein may be used before a manual delivery of a PE tube (20), such that the iontophoresis systems described herein do not necessarily need to be used in conjunction with a PETDD (10). It should also be understood that iontophoresis systems may be used in various other clinical contexts, such that the iontophoresis systems described herein do not necessarily need to be used in the context of a PE tube (20) delivery or in other procedures in a patient's ear. The teachings herein may be readily applied to iontophoresis systems that are used in various other procedures and in various other parts of the human anatomy. Alternative systems and settings in which the teachings herein may be applied will be apparent to those of ordinary skill in the art.
As noted above, vent paths (229) of earplug (220) are configured to allow air to escape working channel (221) while working channel (221) and the patient's ear canal fills with iontophoresis solution. In some instances, it may be desirable to relocate and/or modify the structure associated with vent paths (229). In particular, there may be instances during use of earplug (220) where iontophoresis solution escapes through vent paths (229) and leaves a proximal portion of iontophoresis electrode (252) exposed to air. For instance, if the patient talks, coughs, swallows, cries, yawns, or otherwise moves their lower jaw, the motion associated with such activity may cause variation in the effective volume of the patient's ear canal. This variation of the effective volume of the patient's ear canal may in turn drive at least some iontophoresis solution through vent paths (229). The resulting exposure of even just a portion of iontophoresis electrode (252) to air may adversely affect the iontophoretic performance of earplug (220). In instances where the entire iontophoresis electrode (252) is left exposed to air, the iontophoresis procedure may be completely interrupted until the physician injects more iontophoresis solution into earplug (220).
It may therefore be desirable to relocate and/or modify the structure associated with vent paths (229) in order to provide greater tolerance to variations in the effective volume of the patient's ear canal, to thereby reduce the risk of even a portion of iontophoresis electrode (252) being exposed to air during an iontophoresis procedure. The following example includes a variation of earplug (220) where the vent path is relocated. However, it should be understood that the following example is merely illustrative. Other suitable variations will be apparent to those of ordinary skill in the art in view of the teachings herein.
Earplug (320) is configured to be inserted into a patient's ear and remain there without needing a separate component like a headframe to hold it in place. As will be described in greater detail below, a biocompatible pressure sensitive adhesive is be used to assist in holding earplug (320) in place within a patient's ear canal. Earplug (320) includes a gripping feature (322) that is configured to be gripped and thereby serve as a handle during insertion of earplug (320) in a patient's ear. Earplug (320) also includes a pull-tab (328) that may be gripped and pulled to assist in removing earplug (320) from the patient's ear. Of course, these features are merely illustrative examples, and any other suitable kinds of gripping features may be incorporated into earplug (320). While only one earplug (320) is shown, it should be understood that iontophoresis system (300) may have two earplugs (320) that may be used in both of the patient's ears simultaneously or in a sequence.
As best seen in
Gripping feature (322) is fixedly secured to rigid frame (323). Gripping feature (322) and frame (323) cooperate to define a reservoir (370). Reservoir (370) is in fluid communication with working channel (321). Reservoir (370) extends laterally relative to a longitudinal axis defined by post (325). Thus, reservoir (370) and working channel (321) together form an L-shaped cavity. As will be described in greater detail below, this L-shaped cavity operates to maintain fluid contact with iontophoresis electrode (352) even when a patient's ear canal experiences volumetric changes throughout the iontophoresis procedure. Frame (323) also defines at least one vent path (329), which is also in fluid communication with reservoir (370). Vent path (329) is configured to allow air to escape reservoir (370) when reservoir (370) fills with iontophoresis solution, as will be described in greater detail below. In the present example, vent path (329) is formed as a circular opening with a diameter of approximately 0.025 inches. Alternatively, vent path (329) may have any other suitable size or configuration.
An iontophoresis electrode (352) in the form of a coil extends along at least part of the length of working channel (321). It should be understood that iontophoresis electrode (352) may have any other suitable configuration. Iontophoresis electrode (352) is coupled with control unit (170) via cable (350) and is thereby operable to be activated with a positive voltage as described above. Thus, control unit (170) may activate iontophoresis electrode (352) to provide an electrorepulsive force to the iontophoresis solution ions delivered through apertures (327), to drive the anesthetic of the iontophoresis solution ions into the tympanic membrane (TM) for anesthetization of the tympanic membrane (TM) as described above.
Unlike earplug (220) described above, earplug (320) of the present example is configured to tolerate volumetric changes in a patient's ear during an iontophoresis procedure without letting iontophoresis electrode (352) become exposed to air. In particular, reservoir (370) of the present example is configured to effectively increase the volume of working channel (321), thereby providing a spacing between vent path (329) and iontophoresis electrode (352) that is greater than the spacing between vent paths (229) and iontophoresis electrode (252). In the present example, reservoir (370) and working channel (321) provide a combined volume that is about three times that of working channel (221) described above. In some other examples, reservoir (370) and working channel (321) provide a combined volume that is between about two times and about four times that of working channel (221). Of course, reservoir (370) and working channel (321) may instead provide any other suitable combined volume in relation to the volume of working channel (221).
Unlike earplug (220) described above, earplug (320) of the present example is configured such that vent path (329) is repositioned for management of fluid flow in response to volumetric changes in a patient's ear canal. As can be seen, vent path (329) of the present example is positioned adjacent to reservoir (370) at the furthest lateral point of reservoir (370). As will be described in greater detail below, the above described positioning of vent path (329) directs fluid out of reservoir (370) such that any open space created by displaced fluid remains within reservoir (370). Although vent path (329) of the present example is shown as being integral with an opening for conduit (330), it should be understood that in other examples vent path (329) is a discrete opening in gripping feature (322), spaced away from the point at which conduit (330) enters gripping feature (322).
Once earplug (320) is secured in the patient's ear canal (EC), the operator may begin administration of iontophoresis fluid (390) to the ear canal (EC) via conduit (330) and nozzle (326), as can be seen in
Prior to activation of electrode (352), the operator may remove a fluid delivery device (not shown) such as a syringe from conduit (330). It should be understood that in some circumstances removal of such a device may result in some loss of fluid (390) from working channel (321). By way of example only, in some examples this may result in a loss of about 0.04 cc of fluid (390). As a result, an air pocket (392) of a corresponding volume may form adjacent to vent path (329) in reservoir (370), as shown in
During the iontophoresis procedure, the patient may talk, cough, swallow, cry, yawn, or otherwise move their lower jaw, and the motion associated with such activity may cause variation in the effective volume of the patient's ear canal (EC). Such volumetric changes may cause a pumping action, which will vary the level of fluid (390) in reservoir (370). In some instances, this variation of the level of fluid (390) may displace fluid (390) out of vent path (329), as shown in
In some instances earplug (320) may be used in an inverted position (i.e., at a vertical orientation). In particular, the operator may wish to insert earplug (320) in a patient's ear while the patient's head is oriented toward the ground. During such an operation, reservoir (370) and vent path (329) may generally provide the same function as described above but with different positioning of the air in reservoir (370). As can be seen in
As noted above, a pressure sensitive adhesive may be provided on sealing element (324) in order to provide a more secure and fluid tight fit between sealing element (324) and the wall of the patient's ear canal (EC). It may be desirable to provide a feature that facilitates gripping and positioning of earplug (320) without the operator's fingers getting stuck to the pressure sensitive adhesive on sealing element (324). To that end, earplug (320) of the present example includes a liner strip (380).
The shape of liner strip (380) divides liner strip (380) into four discrete portions (382, 383, 384, 385). In particular, liner strip (380) may be folded along three fold lines (shown in broken lines in
As seen in
As can be seen in
In the present example, the pressure sensitive adhesive is provided about the entire angular perimeter of sealing element (324). Also in the present example, attachment portions (382, 383) are together sized to contact approximately 40% of the surface of sealing element (324) that is coated with pressure sensitive adhesive. Alternatively, attachment portions (382, 383) may cover any other suitable portion of the surface of sealing element (324) that is coated with pressure sensitive adhesive. It should also be understood that pressure sensitive adhesive may be provided about only a portion of the angular perimeter of sealing element (324). For instance, earplug (320) may be configured such that pressure sensitive adhesive is only provided on the zones of sealing element (324) that will contact posterior and anterior walls of the patient's ear canal (EC); but not on the zones of sealing element (324) that will contact posterior and anterior walls of the patient's ear canal (EC).
As another merely illustrative example, a lubricious material (e.g., alcohol, etc.), may be applied to the pressure sensitive adhesive on sealing element (324) to aid in insertion of sealing element (324) in the ear canal (EC); with the lubricious material being configured to evaporate or otherwise dissipate to enable the pressure sensitive adhesive to adhere to the walls of the ear canal (EC) shortly after sealing element (324) is inserted in the ear canal (EC). Still other suitable variations will be apparent to those of ordinary skill in the art in view of the teachings herein.
The following examples relate to various non-exhaustive ways in which the teachings herein may be combined or applied. It should be understood that the following examples are not intended to restrict the coverage of any claims that may be presented at any time in this application or in subsequent filings of this application. No disclaimer is intended. The following examples are being provided for nothing more than merely illustrative purposes. It is contemplated that the various teachings herein may be arranged and applied in numerous other ways. It is also contemplated that some variations may omit certain features referred to in the below examples. Therefore, none of the aspects or features referred to below should be deemed critical unless otherwise explicitly indicated as such at a later date by the inventors or by a successor in interest to the inventors. If any claims are presented in this application or in subsequent filings related to this application that include additional features beyond those referred to below, those additional features shall not be presumed to have been added for any reason relating to patentability.
An apparatus comprising: (a) a rigid body, wherein the rigid body defines: (i) a channel, (ii) reservoir in fluid communication with the channel, and (ii) vent path in fluid communication with the reservoir, wherein the reservoir is configured to provide spacing between the channel and the vent path; (b) a flexible sealing element, wherein the sealing element is positioned distal to the rigid body; (c) a nozzle assembly, wherein the nozzle assembly comprises: (i) a nozzle head, and (ii) a post, wherein the post extends distally through the channel of the rigid body, wherein the nozzle head projects distally from a distal end of the post; and (d) an electrode, wherein the electrode is disposed within the channel of the rigid body, wherein the reservoir extends laterally from a longitudinal axis defined by the electrode.
The apparatus of Example 1, wherein the electrode terminates at a proximal end, wherein the proximal end of the electrode is distal to the reservoir.
The apparatus of any one or more of Examples 1 through 2, wherein the channel and the reservoir together define an L-shape.
The apparatus of any one or more of Examples 1 through 3, wherein the channel extends distally relative to the reservoir, wherein the vent path extends laterally relative to the reservoir.
The apparatus of any one or more of Examples 1 through 4, wherein the sealing element is configured to bear against a wall of an ear canal to thereby define a closed volume outside of a tympanic membrane in the ear canal.
The apparatus of Example 5, wherein the reservoir is in configured to communicate with the closed volume through the channel.
The apparatus of Example 6, wherein the vent path is configured to release excess fluid from the reservoir in response to filling of the closed volume, the channel, and the reservoir with fluid.
The apparatus of any one or more of Examples 6 through 7, wherein the reservoir is configured to provide an air pocket between fluid and the vent path as the closed volume, the channel, and the reservoir are filled with fluid, wherein the channel is configured to maintain submersion of the electrode in the fluid while the air pocket resides in the reservoir.
The apparatus of any one or more of Examples 5 through 8, further comprising a fluid conduit, wherein the fluid conduit is in communication with the channel, wherein the fluid conduit is configured to fill the closed volume, the channel, and the reservoir with fluid.
The apparatus of Example 9, wherein the fluid conduit extends through a conduit opening disposed in the rigid body.
The apparatus of Example 10, wherein the conduit opening and vent path are integral with each other.
The apparatus of any one or more of Examples 10 through 11, wherein the conduit opening and the vent path are separately formed as discrete openings in the rigid body.
The apparatus of any one or more of Examples 1 through 12, further comprising a flexible fluid conduit is fluidly coupled with the post, wherein the post is configured to communicate fluid from the fluid conduit to the nozzle head.
The apparatus of any one or more of Examples 1 through 13, further comprising a pressure sensitive adhesive applied to the sealing element.
The apparatus of Example 14, further comprising a liner strip, wherein the liner strip comprises a pair of attachment portions secured to the pressure sensitive adhesive on the sealing element.
The apparatus of Example 15, wherein the sealing element defines an anterior zone, a posterior zone, a superior zone, and an inferior zone, wherein the attachment portions are configured to engage only the anterior and posterior zones of the sealing element, wherein the attachment portions are configured to not engage the superior and inferior zones of the sealing element.
An apparatus, comprising: (a) an iontophoresis fluid reservoir, wherein the fluid reservoir defines a first volume; (b) a plug configured to define a closed volume in a patient's ear canal outside a tympanic membrane of the patient; (c) a working conduit configured to connect the iontophoresis fluid reservoir with the closed volume, wherein the working conduit defines a second volume; and (d) a drainage conduit passing from the fluid reservoir to a region outside the closed volume and plug; wherein the reservoir, plug, working conduit, and drainage conduit are configured to supply iontophoresis fluid through the working conduit, wherein the first volume of the fluid reservoir is greater than the second volume of the working conduit.
An apparatus, comprising: (a) a plug configured to define a closed volume in a patient's ear canal outside a tympanic membrane of the patient, wherein the plug defines a channel configured to communicate with the closed volume, wherein the plug further includes a sealing element having a pressure sensitive adhesive thereon; (b) an iontophoresis electrode situated in the channel; and (c) a liner strip, wherein the liner strip comprises: (i) a pair of attachment portions, wherein each attachment portion is defined by a corresponding fold in the liner strip, wherein each attachment portion is configured cover two discrete portions the pressure sensitive adhesive on the sealing element, and (ii) a pair of gripping portions, wherein each gripping portion is defined by a fold in the liner strip, wherein each attachment portion is disposed on a distal end of a respective gripping portion.
The apparatus of Example 18, wherein the attachment portions extend proximally from corresponding distal ends of the gripping portions.
The iontophoresis apparatus of any one or more of Examples 18 through 19, wherein each attachment portion comprises a generally curved shape contoured to complement a curvature of the sealing element.
It should be understood that any of the examples described herein may include various other features in addition to or in lieu of those described above. By way of example only, any of the devices herein may also include one or more of the various features disclosed in any of the various references that are incorporated by reference herein. It should also be understood that any one or more of the teachings, expressions, embodiments, examples, etc. described herein may be combined with any one or more of the other teachings, expressions, embodiments, examples, etc. that are described herein. The above-described teachings, expressions, embodiments, examples, etc. should therefore not be viewed in isolation relative to each other. Various suitable ways in which the teachings herein may be combined will be readily apparent to those of ordinary skill in the art in view of the teachings herein. Such modifications and variations are intended to be included within the scope of the claims.
It should be appreciated that any patent, publication, or other disclosure material, in whole or in part, that is said to be incorporated by reference herein is incorporated herein only to the extent that the incorporated material does not conflict with existing definitions, statements, or other disclosure material set forth in this disclosure. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.
Versions described above may be designed to be disposed of after a single use, or they can be designed to be used multiple times. Versions may, in either or both cases, be reconditioned for reuse after at least one use. Reconditioning may include any combination of the steps of disassembly of the device, followed by cleaning or replacement of particular pieces, and subsequent reassembly. In particular, some versions of the device may be disassembled, and any number of the particular pieces or parts of the device may be selectively replaced or removed in any combination. Upon cleaning and/or replacement of particular parts, some versions of the device may be reassembled for subsequent use either at a reconditioning facility, or by a user immediately prior to a procedure. Those skilled in the art will appreciate that reconditioning of a device may utilize a variety of techniques for disassembly, cleaning/replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of the present application.
By way of example only, versions described herein may be sterilized before and/or after a procedure. In one sterilization technique, the device is placed in a closed and sealed container, such as a plastic or TYVEK bag. The container and device may then be placed in a field of radiation that can penetrate the container, such as gamma radiation, x-rays, or high-energy electrons. The radiation may kill bacteria on the device and in the container. The sterilized device may then be stored in the sterile container for later use. A device may also be sterilized using any other technique known in the art, including but not limited to beta or gamma radiation, ethylene oxide, or steam.
Having shown and described various embodiments of the present invention, further adaptations of the methods and systems described herein may be accomplished by appropriate modifications by one of ordinary skill in the art without departing from the scope of the present invention. Several of such potential modifications have been mentioned, and others will be apparent to those skilled in the art. For instance, the examples, embodiments, geometrics, materials, dimensions, ratios, steps, and the like discussed above are illustrative and are not required. Accordingly, the scope of the present invention should be considered in terms of the following claims and is understood not to be limited to the details of structure and operation shown and described in the specification and drawings.
This application is a continuation of U.S. application Ser. No. 16/028,687 filed Jul. 6, 2018 titled “Earplug Assembly for Iontophoresis System” (now U.S. Pat. No. 10,842,676) which is a divisional of and claims priority to U.S. patent application Ser. No. 14/800,869, filed Jul. 16, 2015 and also titled “Earplug Assembly for Iontophoresis System” (now U.S. Pat. No. 10,016,304). Both applications are incorporated herein by reference as if reproduced in full below.
Number | Name | Date | Kind |
---|---|---|---|
858673 | Roswell | Jul 1907 | A |
1920006 | Dozier et al. | Jul 1933 | A |
2458884 | Volkmann | Jan 1949 | A |
3741197 | Sanz et al. | Jun 1973 | A |
3888258 | Akiyama | Jun 1975 | A |
3897786 | Garnett et al. | Aug 1975 | A |
3913584 | Walchle et al. | Oct 1975 | A |
3948271 | Akiyama | Apr 1976 | A |
3991755 | Vernon et al. | Nov 1976 | A |
4149533 | Ishikawa et al. | Apr 1979 | A |
4206756 | Grossan | Jun 1980 | A |
4406282 | Parker et al. | Sep 1983 | A |
4468218 | Armstrong | Aug 1984 | A |
4473073 | Darnell | Sep 1984 | A |
4552137 | Strauss | Nov 1985 | A |
4564009 | Brinkhoff | Jan 1986 | A |
4601294 | Danby et al. | Jul 1986 | A |
4712537 | Pender | Dec 1987 | A |
4964850 | Bouton et al. | Oct 1990 | A |
4968296 | Ritch et al. | Nov 1990 | A |
4971076 | Densert et al. | Nov 1990 | A |
5026378 | Goldsmith, III | Jun 1991 | A |
5044373 | Northeved et al. | Sep 1991 | A |
5047007 | McNichols et al. | Sep 1991 | A |
5053040 | Goldsmith, III | Oct 1991 | A |
5107861 | Narboni | Apr 1992 | A |
5135478 | Sibalis | Aug 1992 | A |
5160316 | Henley | Nov 1992 | A |
5254081 | Maurer et al. | Oct 1993 | A |
5254120 | Cinberg et al. | Oct 1993 | A |
5261903 | Dhaliwal et al. | Nov 1993 | A |
D352780 | Glaeser et al. | Nov 1994 | S |
5421818 | Arenberg | Jun 1995 | A |
5466239 | Cinberg et al. | Nov 1995 | A |
5496329 | Reisinger | Mar 1996 | A |
D378611 | Croley | Mar 1997 | S |
5610988 | Miyahara | Mar 1997 | A |
5643280 | Del Rio et al. | Jul 1997 | A |
5674196 | Donaldson et al. | Oct 1997 | A |
D387863 | Herman et al. | Dec 1997 | S |
5707383 | Bays et al. | Jan 1998 | A |
5792100 | Shantha | Aug 1998 | A |
5804957 | Coln | Sep 1998 | A |
5810848 | Hayhurst | Sep 1998 | A |
5827295 | Del Rio et al. | Oct 1998 | A |
5893828 | Uram | Apr 1999 | A |
5979072 | Collins, II | Nov 1999 | A |
D418223 | Phipps et al. | Dec 1999 | S |
D420741 | Croley | Feb 2000 | S |
6045528 | Arenberg et al. | Apr 2000 | A |
D424197 | Sydlowski et al. | May 2000 | S |
6059803 | Spilman | May 2000 | A |
D426135 | Lee | Jun 2000 | S |
6137889 | Shennib et al. | Oct 2000 | A |
6148821 | Falco | Nov 2000 | A |
6183469 | Thapliyal et al. | Feb 2001 | B1 |
6200280 | Brenneman et al. | Mar 2001 | B1 |
6206888 | Bicek et al. | Mar 2001 | B1 |
6245077 | East et al. | Jun 2001 | B1 |
6251121 | Saadat | Jun 2001 | B1 |
6295469 | Linkwitz et al. | Sep 2001 | B1 |
D450843 | McGuckin, Jr. et al. | Nov 2001 | S |
6347246 | Perrault et al. | Feb 2002 | B1 |
6358231 | Schindler et al. | Mar 2002 | B1 |
6440102 | Arenberg et al. | Aug 2002 | B1 |
6475138 | Schechter et al. | Nov 2002 | B1 |
6512950 | Li et al. | Jan 2003 | B2 |
6514261 | Randall et al. | Feb 2003 | B1 |
6520939 | Lafontaine | Feb 2003 | B2 |
6522827 | Loeb et al. | Feb 2003 | B1 |
6553253 | Chang | Apr 2003 | B1 |
6640121 | Telischi et al. | Oct 2003 | B1 |
6645173 | Liebowitz | Nov 2003 | B1 |
6648873 | Arenberg et al. | Nov 2003 | B2 |
6663575 | Leysieffer | Dec 2003 | B2 |
6682558 | Tu et al. | Jan 2004 | B2 |
6770080 | Kaplan et al. | Aug 2004 | B2 |
6916159 | Rush et al. | Jul 2005 | B2 |
7123957 | Avrahami | Oct 2006 | B2 |
7127285 | Henley et al. | Oct 2006 | B2 |
7137975 | Miller et al. | Nov 2006 | B2 |
D535027 | James et al. | Jan 2007 | S |
7160274 | Ciok et al. | Jan 2007 | B2 |
7344507 | Briggs et al. | Mar 2008 | B2 |
7351246 | Epley | Apr 2008 | B2 |
7381210 | Zarbatany et al. | Jun 2008 | B2 |
D595410 | Luzon | Jun 2009 | S |
7563232 | Freeman et al. | Jul 2009 | B2 |
D598543 | Vogel et al. | Aug 2009 | S |
7654997 | Makower et al. | Feb 2010 | B2 |
7677734 | Wallace | Mar 2010 | B2 |
7704259 | Kaplan et al. | Apr 2010 | B2 |
7749254 | Sobelman et al. | Jul 2010 | B2 |
D622842 | Benoist | Aug 2010 | S |
3052693 | Shahoian | Nov 2011 | A1 |
8192420 | Morriss et al. | Jun 2012 | B2 |
8249700 | Clifford et al. | Aug 2012 | B2 |
8409175 | Lee et al. | Apr 2013 | B2 |
8425488 | Clifford et al. | Apr 2013 | B2 |
8452392 | Morriss et al. | May 2013 | B2 |
8498425 | Graylin | Jul 2013 | B2 |
8518098 | Roeder et al. | Aug 2013 | B2 |
8702722 | Shahoian | Apr 2014 | B2 |
8840602 | Morriss et al. | Sep 2014 | B2 |
8849394 | Clifford et al. | Sep 2014 | B2 |
9011363 | Clopp et al. | Apr 2015 | B2 |
9023059 | Loushin et al. | May 2015 | B2 |
9216112 | Clifford et al. | Dec 2015 | B2 |
9364648 | Girotra et al. | Jun 2016 | B2 |
9387124 | Clifford | Jul 2016 | B2 |
9392229 | Morriss et al. | Jul 2016 | B2 |
9707131 | Shahoian | Jul 2017 | B2 |
9713710 | Morriss et al. | Jul 2017 | B2 |
9833601 | Clifford et al. | Dec 2017 | B2 |
9950157 | Morriss et al. | Apr 2018 | B2 |
10016304 | Ray et al. | Jul 2018 | B2 |
10130808 | Kermani et al. | Nov 2018 | B2 |
10195369 | Andreas et al. | Feb 2019 | B2 |
10258776 | Clifford et al. | Apr 2019 | B2 |
10478344 | Girotra et al. | Nov 2019 | B2 |
20020026125 | Leysieffer | Feb 2002 | A1 |
20020069883 | Hirchenbain | Jun 2002 | A1 |
20020111585 | Lafontaine | Aug 2002 | A1 |
20020138091 | Pflueger | Sep 2002 | A1 |
20020161379 | Kaplan et al. | Oct 2002 | A1 |
20020169456 | Tu et al. | Nov 2002 | A1 |
20030060799 | Arenberg et al. | Mar 2003 | A1 |
20030093057 | Zhang et al. | May 2003 | A1 |
20030120292 | Park et al. | Jun 2003 | A1 |
20030199791 | Boecker et al. | Oct 2003 | A1 |
20040054339 | Ciok et al. | Mar 2004 | A1 |
20050094835 | Doty | May 2005 | A1 |
20050154357 | Pinel | Jul 2005 | A1 |
20050182385 | Epley | Aug 2005 | A1 |
20050203552 | Laufer et al. | Sep 2005 | A1 |
20050235422 | Wallace | Oct 2005 | A1 |
20050240147 | Makower et al. | Oct 2005 | A1 |
20050284479 | Schrader et al. | Dec 2005 | A1 |
20060079957 | Chin et al. | Apr 2006 | A1 |
20060142700 | Sobelman et al. | Jun 2006 | A1 |
20060155304 | Kaplan et al. | Jul 2006 | A1 |
20060177080 | Smith | Aug 2006 | A1 |
20070003096 | Nam | Jan 2007 | A1 |
20070066946 | Haggstrom et al. | Mar 2007 | A1 |
20070078372 | Reddy et al. | Apr 2007 | A1 |
20070183613 | Juneau et al. | Aug 2007 | A1 |
20070233222 | Roeder et al. | Oct 2007 | A1 |
20080011308 | Fleming | Jan 2008 | A1 |
20080051804 | Cottler et al. | Feb 2008 | A1 |
20080058756 | Smith | Mar 2008 | A1 |
20080065002 | Lobl et al. | Mar 2008 | A1 |
20080107287 | Beard | May 2008 | A1 |
20080212416 | Polonio et al. | Sep 2008 | A1 |
20080262468 | Clifford et al. | Oct 2008 | A1 |
20080262508 | Clifford et al. | Oct 2008 | A1 |
20080262510 | Clifford | Oct 2008 | A1 |
20090163848 | Morriss et al. | Jun 2009 | A1 |
20090209972 | Loushin et al. | Aug 2009 | A1 |
20090262510 | Pekkarinen et al. | Oct 2009 | A1 |
20090270807 | Mas et al. | Oct 2009 | A1 |
20090299344 | Lee et al. | Dec 2009 | A1 |
20100030131 | Morriss et al. | Feb 2010 | A1 |
20100041447 | Graylin | Feb 2010 | A1 |
20100061581 | Soetejo et al. | Mar 2010 | A1 |
20100198135 | Morriss et al. | Aug 2010 | A1 |
20100300460 | Falco et al. | Dec 2010 | A1 |
20110001564 | Hori | Jan 2011 | A1 |
20110015645 | Liu et al. | Jan 2011 | A1 |
20110048414 | Hoekman et al. | Mar 2011 | A1 |
20110268303 | Ahsani | Nov 2011 | A1 |
20110288559 | Shahoian | Nov 2011 | A1 |
20120109070 | Elsamahy et al. | May 2012 | A1 |
20120310145 | Clifford et al. | Dec 2012 | A1 |
20130090544 | Clifford et al. | Apr 2013 | A1 |
20130190678 | Andreas et al. | Jul 2013 | A1 |
20130197426 | Morriss et al. | Aug 2013 | A1 |
20130223702 | Holsing et al. | Aug 2013 | A1 |
20140102461 | Girotra | Apr 2014 | A1 |
20140194891 | Shahoian | Jul 2014 | A1 |
20140276352 | Kermani et al. | Sep 2014 | A1 |
20140276906 | Andreas et al. | Sep 2014 | A1 |
20150068539 | Morriss et al. | Mar 2015 | A1 |
20160361204 | Girotra et al. | Dec 2016 | A1 |
20160375204 | Andreas et al. | Dec 2016 | A1 |
20170014272 | Ray et al. | Jan 2017 | A1 |
20170028193 | Morriss et al. | Feb 2017 | A1 |
20180085563 | Clifford et al. | Mar 2018 | A1 |
20180256894 | Morriss et al. | Sep 2018 | A1 |
20180304059 | Clifford et al. | Oct 2018 | A1 |
20190083780 | Kermani et al. | Mar 2019 | A1 |
20190298940 | Andreas et al. | Oct 2019 | A1 |
Number | Date | Country |
---|---|---|
2424347 | Oct 2004 | CA |
86105171 | Mar 1987 | CN |
2087067 | Oct 1991 | CN |
2409940 | Dec 2000 | CN |
203898546 | Oct 2014 | CN |
19618585 | Nov 1997 | DE |
0214527 | Mar 1987 | EP |
2526656 | Nov 1983 | FR |
S59129815 | Aug 1984 | JP |
H07116190 | May 1995 | JP |
2010524584 | Jul 2010 | JP |
9210223 | Jun 1992 | WO |
1992010223 | Jun 1992 | WO |
1999017825 | Apr 1999 | WO |
2002043795 | Jun 2002 | WO |
2006119512 | Nov 2006 | WO |
2008030485 | Mar 2008 | WO |
2008036368 | Mar 2008 | WO |
2008131195 | Oct 2008 | WO |
2009010788 | Jan 2009 | WO |
2010014894 | Feb 2010 | WO |
2011081772 | Jul 2011 | WO |
2013016098 | Jan 2013 | WO |
2013181009 | Dec 2013 | WO |
2014158543 | Oct 2014 | WO |
2017011777 | Jan 2017 | WO |
Entry |
---|
JP OA for App No. 2018-500895 dated Nov. 25, 2020, 4 pages. |
AU Office Action for App No. 2016291677 dated May 13, 2020; 7 pages. |
CN Office Action for Patent Application No. 2016800495548; 9 pages. |
JP Office Action for Patent Application No. 2018-500895 dated Jun. 12, 2020; 4 pages. |
First Office Action for Chinese Application No. 201680049554.8, dated Sep. 19, 2019; 19 pages. |
U.S. Appl. No. 60/912,902, filed Apr. 19, 2007. |
Patent Examination Report No. 1 for Australian Patent Application No. 2008242735, dated Aug. 8, 2012; 3 pages. |
Patent Examination Report No. 1 for Australian Patent Application No. 2013209354, dated Oct. 13, 2014; 5 pages. |
First Office Action for Chinese Patent Application No. 200880020861.9, dated Jul. 12, 2011; 10 pages. |
Second Office Action for Chinese Patent Application No. 20080020861.9, dated Dec. 31, 2011; 3 pages. |
Search Report for Chinese Patent Application No. 20130047126.X, dated Mar. 6, 2015; 2 pages. |
Second Office Action for Chinese Patent Application No. 20130047126.X, dated Mar. 16, 2015; 10 pages. |
Office Action for European Application No. 08746237.0, dated Mar. 24, 2016; 3 pages. |
Office Action for European Application No. 08746237.0, dated Aug. 4, 2015; 7 pages. |
Supplementary Partial Search Report for European Application No. 08746237.0, dated Jun. 30, 2014; 9 pages. |
Notification of Reasons for Refusal for Japanese Patent Application No. 2010-504267, dated Nov. 20, 2012; 4 pages. |
Notification for Reason for Refusal for Japanese Aptent Applicaton No. 2010-504267, dated Nov. 12, 2013; 4 pages. |
International Search Report for International Application No. PCT/US2008.060779, dated Sep. 3, 2008. |
Written Opinion for International Application No. PCT.US2008/060779, dated Sep. 3, 2008. |
Office Action for U.S. Appl. No. 11/749,733, dated Jun. 10, 2009; 13 pages. |
Office Action for U.S. Appl. No. 11/749,733, dated Dec. 2, 2008; 9 pages. |
U.S. Appl. No. 61/085,360, filed Jul. 31, 2008. |
Patent Examination Report No. 1 for Australian Applicatin No. 2009276384, dated Apr. 14, 2014; 3 pages. |
Office Action for Canadian Application No. 2,732,595, dated Dec. 8, 2015; 4 pages. |
Office Action for Russian Application No. 2011-07228, dated May 24, 2013. |
International Search Report for International Application No. PCT/US2009/052395, dated Nov. 6, 2009. |
Written Opinion for International Application No. PCT/US2009/052395, dated Nov. 6, 2009. |
Patent Examination Reprot No. 1 for Australian Applicaton No. 2010337214, dated Feb. 27, 2015; 3 pages. |
Office Action for Chinese Application No. 201080065012.2, dated Mar. 31, 2016; 20 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2010058718, dated Feb. 17, 2011; 12 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2010/042128, dated Aug. 27, 2010; 10 pages. |
Office Action for Australian Application No. 2012287268, dated Feb. 11, 2016. |
Office Action for European Application No. 12743007.2, dated Jul. 21, 2016; 5 pages. |
Notification of Reasons for Refusal for Japanese Application No. 2014-522882, dated May 31, 2016. |
International Search Report and Written Opinion for International Application No. PCT/US2012/047179, dated Mar. 11, 2013; 15 pages. |
First Office Action for Chinese Patent Application No. 201380027926.3, dated May 3, 2016. |
International Search Report and Written Opinion for International Applicatin No. PCT/US2013/041816, dated Sep. 16, 2013; 14 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2014/018017, dated May 22, 2014; 12 pages. |
Office Action for U.S. Appl. No. 14/800,869, dated Aug. 24, 2017; 11 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2016/042577, dated Dec. 6, 2016; 14 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2009/069388, dated Jun. 30, 2010; 16 pages. |
Comeau, M. et al., “Local anesthetisa of the Ear by Iontophoresis,” vol. 98, Arch. Otolaryngol., pp. 114-120 (Aug. 1973). |
Comeau, M. et al., “Anesthesia of the Human Tympanic Membrane by Iontophoresis of a Local Anesthetic,” The Larynogoscope, vol. 88, pp. 277-285 (1978). |
Echols, D.F. et al., “Anesthesia of the Ear by Iontophoresis of Lidocaine,” Arch. Otolaryngol., vol. 101, pp. 418-421 (Jul. 1975). |
Epley, J.M., “Modified Technique of Iontophoretic Anesthesia for Myringotomy in Children,” Arch. Otolaryngol., vol. 103, pp. 358-360 (Jun. 1977). |
Hasegawa, M. et al., “Iontophoretic anaesthesia of the tympanic membrae,” Clinical Otolaryngoloy, vol. 3, pp. 63-66 (1978). |
Ramsden, R.T. et al., “Anaesthesia of the tympanic membrane using iontophoresis,” The Journal of Laryngology and Otology, 56(9): 779-785 (Sep. 1977). |
“Definition of Plenum,” Compact Oxford English Dictionary (online), Retrieved from the Internet: <hhtp://oxforddictionaries.com/definition/english/plenum>, Retrieved on Aug. 14, 2012, 1 page. |
Medtronic XOMED, “Activent Antimicrobial Ventilation Tubes,” Rev.1.1, pp. 1-4, 2002, Jacksonville, FL. |
Micomedics Innovative Surgical Products, “Micromedics Tympanostomy Tubes,” (online), Relieved on Jul. 15, 2010, retrived from the internet <URL: http://www.micromedics-usa.com/products/otology/micromedicstubes.htm>, 7 pages. |
Second Office Action for Chinese Patent Application No. 200880020861.9, dated Dec. 31, 2011, 3 pages. |
Search Report for Chinese Patent Application No. 201310047126.X, dated Mar. 6, 2015, 2 pages. |
Second Office Action for Chinese Patent Application No. 201310047126.X, dated Mar. 16, 2015, 10 pages. |
Notification of Reasons for Refusal for Japanese Patent Application No. 2010-504267, dated Nov. 12, 2013, 4 pages. |
Patent Examination Report No. 1 for Austrailian Application No. 2009276384, dated Apr. 14, 2014, 3 pages. |
Patent Examination Report No. 1 for Australian Application No. 2010337214, dated Feb. 27, 2015, 3 pages. |
International Search Report for International Application No. PCT/US2010/058718, dated Feb. 17, 2011. |
Written Opinion for International Application No. PCT/US2010/058718, dated Feb. 17, 2011. |
International Search Report for International Application No. PCT/US2010/042128, dated Aug. 27, 2010. |
International Search Report for International Application No. PCT/US2012/047179, dated Mar. 11, 2013. |
Written Opinion for International Application No. PCT/US2012/047179, dated Mar. 11, 2013. |
International Search Report for International Application No. PCT/US2013/041816, dated Sep. 16, 2013, 7 pages. |
Written Opinion for International Application No. PCT/US2013/041816, dated Sep. 16, 2013, 7 pages. |
International Search Report for International Application No. PCT/US2009/069388, dated Jun. 30, 2010. |
Comeau, M. et al., “Local Anesthesia of the Ear by Iontophoresis,” vol. 98, Arch. Otolaryngol., pp. 114-120 (Aug. 1973). |
Comeau, M. et al., “Anesthesia of the Human Tympanic Membrane by Iontophoresis of a Loval Anesthetic,” The Larynogoscope, vol. 88, pp. 277-285 (1978). |
Epley, J. M., “Modified Technique of lontophoretic Anesthesia for Myringotomy in Children,” Arch. Otolaryngol., vol. 103, pp. 358-360 (Jun. 1977). |
Hasegawa, M. et al., “lontophorectic anaesthesia of the tympanic membrane,” Clinical Otolaryngoloy, vol. 3, pp. 33-66 (1978). |
Ramsden, R. T. et al., “Anaesthesia of the tympanic membraine using iontophoresis,” The Journal of Laryngology and Otology, 56(9): 779-785 (Sep. 1977). |
“Definition of Plenum,” Compact Oxford English Dictionary [online], Retrieved from the Internet: <http://oxforddictionaries.com/definition/english/plenum>, Retrieved on Aug. 6, 2012, 2 pages. |
Definition of Plenum,: Merriam-Webster's Online Dictionary, 11th Edition [online], Retrieved from the Internet: <http://www.merriam-webster.com/dictionary/plenum>, Retrieved on Aug. 14, 2012, 1 page. |
Micromedics Innovative Surgical Products, “Micromedics Tympanostomy Tubes,” [online], Retrieved on Jul. 15, 2010, Retrieved from the Internet <URL: http://www.micromedics-usa.com/products/otology/micromedicstubes.htm>, 7 pages. |
Number | Date | Country | |
---|---|---|---|
20210015673 A1 | Jan 2021 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14800869 | Jul 2015 | US |
Child | 16028687 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16028687 | Jul 2018 | US |
Child | 17063115 | US |